These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25569277)

  • 1. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
    Younes SF; Aiad H; Kandil M; El Kalashy FS
    Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin expression of endometrium hyperplasia and endometrioid carcinoma.
    Dagli AF; Aydin S; Kocdor H; Gurates B; Sahin I; Catak Z; Ozercan MR; Ozercan IH
    Gynecol Endocrinol; 2011 Mar; 27(3):199-204. PubMed ID: 20712427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker.
    Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M
    Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction.
    Ørbo A; Kaino T; Arnes M; Larsen K; Pettersen I; Moe B
    Acta Obstet Gynecol Scand; 2009; 88(11):1234-42. PubMed ID: 19900140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
    Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
    Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
    Zhou WX; Liang ZY; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
    D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
    Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
    Youssef MY; Mohamed MA
    Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
    Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
    Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature.
    Rakha E; Wong SC; Soomro I; Chaudry Z; Sharma A; Deen S; Chan S; Abu J; Nunns D; Williamson K; McGregor A; Hammond R; Brown L
    Am J Surg Pathol; 2012 Nov; 36(11):1683-90. PubMed ID: 23073327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.